Inactive Instrument

Human Genome Sciences Share Price

Stocks

End-of-day quote Nasdaq Other stock markets
- ^USD	-

26/07/12	Actelion Ltd : Exclusive: Human Genome rejected Amgen's $7 billion bid in 2010: sources	RE
16/07/12	BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion	RE

26/07/12	Actelion Ltd : Exclusive: Human Genome rejected Amgen's $7 billion bid in 2010: sources	RE
16/07/12	BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion	RE
16/07/12	GlaxoSmithKline plc : Exclusive: GSK set for Human Genome takeover - sources	RE
15/07/12	GlaxoSmithKline plc : GSK in weekend talks to buy Human Genome: sources	RE
03/07/12	GlaxoSmithKline plc : GSK lines up nominees for Human Genome board	RE
29/06/12	GlaxoSmithKline plc : GSK further extends $2.6 billion Human Genome offer	RE
08/06/12	GlaxoSmithKline plc : GSK extends its $2.6 billion offer for Human Genome	RE
01/06/12	GlaxoSmithKline plc : Court denies request to curb Human Genome takeover defense	RE
31/05/12	Genmab A/S : Exclusive: GlaxoSmithKline eyes replacing Human Genome board	RE
30/05/12	GlaxoSmithKline plc : Exclusive: GSK eyes replacing Human Genome board	RE
23/05/12	GlaxoSmithKline plc : GSK to drop Human Genome bid if "poison pill" stands	RE
09/05/12	SANOFI : GSK goes hostile with $2.6 billion Human Genome offer	RE
02/05/12	Ardea Biosciences, Inc. : Biotech targets fight back as Big Pharma circles	RE

03/08/12	Human Genome Sciences : ANNOUNCES REQUIRED OFFER TO REPURCHASE IN RESPECT OF ITS 3.00% CONVERTIBLE SENIOR NOTES DUE 2018	PU
26/07/12	Human Genome Sciences : Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Human Genome Sciences, Inc.	PR
20/07/12	Human Genome Sciences : Law Offices of Howard G. Smith Announces Investigation of Human Genome Sciences Inc. Board of Directors for Potential Breaches of Fiduciary Duty	BU
18/07/12	Human Genome Sciences : Law Office of Brodsky & Smith, LLC Announces Investigation of Human Genome Sciences, Inc.	PR
17/07/12	Human Genome Sciences : Inc. Board of Directors Under Investigation for Potential Breaches of Fiduciary Duty by Glancy Binkow & Goldberg LLP	BU

25/07/12	GlaxoSmithKline plc : GlaxoSmithKline-T2 inférieur aux attentes, baisse du titre
16/07/12	GSK rachète Human Genome pour 3,0 milliards de dollars
16/07/12	GSK annonce le rachat de Human Genome pour $3,0 milliards
16/07/12	Human Genome : grimpe avec la nouvelle offre de GSK.
16/07/12	Wall Street ouvre en léger recul, mais Citi monte

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LONZA GROUP AG	+0.58%	+2.06%	+2.92%	+10.86%	50.44B
REVOLUTION MEDICINES, INC.	-2.22%	-1.25%	+385.40%	+586.81%	40.63B
IQVIA HOLDINGS INC.	-0.54%	+0.39%	+25.57%	-5.28%	34.88B
BEONE MEDICINES AG	-1.36%	+0.35%	+17.88%	+55.14%	33.67B
CELLTRION, INC.	+1.21%	-0.79%	+4.46%	+35.18%	26.29B
ASCENDIS PHARMA A/S	-1.81%	-1.48%	-	-	17.11B
MEDPACE HOLDINGS, INC.	+0.51%	-3.47%	+63.97%	+122.60%	15.29B
IONIS PHARMACEUTICALS, INC.	-9.37%	-28.79%	+37.45%	+39.42%	10.62B
EUROFINS SCIENTIFIC SE	+0.23%	-0.58%	+13.76%	+21.11%	13.74B
Average	-0.37%	-2.12%	+68.93%	+108.23%	26.96B
Weighted average by Cap.	-0.47%	-0.03%	+84.16%	+131.10%

Employees

Sector